Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine for heart rate control in septic shock (multi-arm, multi-stage trial)
2018-003801-24Phase 2Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in septic shock comparing Ivabradine arm with Placebo arm (2 arms). Primary endpoint: Heart rate control and 28-day survival. Started May 2019; status: active.
02
Drugs
ivabradine
03
Conditions
septic shock
Beyond the preview
Go deeper on 2018-003801-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003801-24.